Anchiano Therapeutics Names CMO

David Kerstein, M.D., has been named chief medical officer of Anchiano Therapeutics, a clinical-stage biopharma company focused on novel therapies to treat cancer. Dr. Kerstein is an accomplished physician experienced in leading clinical drug development programs for oncology therapies.

"We are thrilled to have David, a skilled medical lead and accomplished clinical drug strategist, join our team at Anchiano," said Frank Haluska, president and chief executive officer of Anchiano Therapeutics. "We look forward to his medical leadership."

"I am eager to contribute to Anchiano’s mission to develop a DNA-based cancer therapy for the treatment of malignancies in the urinary bladder," said Dr. Kerstein.

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.